|drug62||A $20 Survey Incentive Wiki||1.00|
|drug2779||Racial/Ethnic Frame Wiki||1.00|
|drug61||A $10 Survey Incentive Wiki||1.00|
|drug1181||Emphasis of Government Involvement Wiki||1.00|
|drug1180||Emphasis of Academic Researchers Involvement Wiki||1.00|
|drug2211||No Messaging Wiki||1.00|
|drug1103||Duty Frame Wiki||1.00|
|drug1215||Essential oils Wiki||1.00|
|drug926||Cost-Benefit Frame Wiki||1.00|
|D003141||Communicable Diseases NIH||0.07|
There is one clinical trial.
The purpose of this study is to assess the ability of regular gargling to eliminate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the throat and nasopharynx. This 4 arms interventional study compares the effect of gargling using povidone-iodine, essential oils- based, tap water with control (no intervention) among Stage 1 coronavirus disease-2019 (COVID-19) patients. Findings from this study will provide new insight into the importance of gargling in the treatment and prevention of COVID-19.
Description: Viral clearance is defined as two negative RT-PCR (of swabs from oropharynx and nasopharynx) results at least 24 hours apartMeasure: Number of Participants With Early Viral Clearance Time: Day 6
Description: RT-PCR (swabs from oropharynx and nasopharynx) taken at day 12Measure: Number of Participants With Negative RT-PCR Results Time: Day 12
Description: Presence of signs and symptoms of more severe COVID19 Based symptoms diary and clinical evaluationMeasure: Number of Patients That Progress to More Severe Disease Time: Day 12
Description: abnormal chest x-ray or CT scanMeasure: Number of Patients With Abnormal Radiological Findings Time: Day 0-14
Description: Abnormal absolute lymphocytic count Abnormal C-reactive proteinMeasure: Number of Patients With Abnormal Laboratory Findings Time: Day 0-14
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports